HESA Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Notice of meeting Amended
Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting No. 6
Wednesday, April 13, 2016, 3:30 p.m. to 5:30 p.m.
3:30 p.m. to 5:00 p.m.
Witnesses
Canadian Agency for Drugs and Technologies in Health
• Brian O'Rourke, President and Chief Executive Officer
Canadian Institute for Health Information
• Brent Diverty, Vice President of Programs
• Michael Gaucher, Director, Pharmaceuticals and Health Workforce Information Services
Department of Health
• Abby Hoffman, Assistant Deputy Minister, Strategic Policy Branch
• Scott Doidge, Director General, Non-Insured Health Benefits, First Nations and Inuit Health BranchAmended
• Frances Hall, Director, Office of Pharmaceuticals Management Strategies, Strategic Policy Branch
Patented Medicine Prices Review Board
• Tanya Potashnik, Director, Policy and Economic Analysis Branch
• Guillaume Couillard, Director, Board Secretariat, Communications and Strategic Planning
5:00 p.m. to 5:30 p.m.
(In Camera)
Clerk of the Committee
David Gagnon (613-995-4108)
2016/04/13 9:39 a.m.